We next evaluated the therapeutic impact of apalutamide therapy by examining its effect on survival in conditional Pten/Trp53 double knockout (DKO) mice employing a model of advanced castration-naïve prostate cancer (Figure 1E and Supplementary Figure S1A). This evidence concerns the gene PTEN and Familial prostate cancer.